Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Menglin Li, Yi-Meng Li, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Chencong Wang, Qi Chen, Xiaolu Zhu, Yun He, YuanYuan Zhang, Qian Jiang, Hao Jiang, Jin Lu, YingJun Chang, Xiaosu Zhao, Xiangyu Zhao, Xiao Jun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 1486.

https://doi.org/10.1182/blood-2024-204777

Published: 2024

Journal Articles

AIM2 Mediates Immune Evasion of Acute Myeloid Leukemia Cells

Xiaoting Liang, Yijie Zhai, Siqi Li, Huiyun Peng, Yun Huang, Youxin Feng, Tiebang Kang, Yizhou Zou, Xiao Jun Huang, Yingjun Chang, Mi Deng

Blood (2024) 144 (Supplement 1): 1345.

https://doi.org/10.1182/blood-2024-194621

Published: 2024

Journal Articles

Outcome for Mothers and Neonates Among Pregnant Women with Von Willebrand Disease: A Prospective Nationwide Multicenter Study

Qiusha Huang, Xiaolu Zhu, Yun He, HaiXia Fu, Qi Chen, Peng Zhao, Jin Wu, YingJun Chang, LanPing Xu, Xue Xu, Xiaohong Zhang, Jianliu Wang, Xiaojun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 3703.

https://doi.org/10.1182/blood-2024-205168

Published: 2024

Journal Articles

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Blood (2023) 142 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2023-184415

Published: 2023

Journal Articles

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

Xiaolu Zhu, Hui Liu, Zhao Wang, Zhongxing Jiang, Liangming Ma, Min Wang, Jiamin Zhang, Zhuoyu An, Yejun Wu, Yun He, Haixia Fu, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiao Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2589.

https://doi.org/10.1182/blood-2023-184342

Published: 2023

Journal Articles

MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study

Yang Cao, Wenxuan Huo, Yang Yang, Jiayu Huang, Yu Wang, Liang Huang, Yingjun Chang, Xiaoxia Hu, Xiaodong Mo

Blood (2023) 142 (Supplement 1): 3620.

https://doi.org/10.1182/blood-2023-185667

Published: 2023

Journal Articles

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Song Wang, Yan Zhu, Xiaolu Zhu, Haixia Fu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Chenhua Yan, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2023-184380

Published: 2023

Journal Articles

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Menglin Li, Haixia Fu, Yi Liu, Hui Liu, Ru Feng, Zhao Wang, Jingwen Wang, Yuxiu Chen, Qingyuan Qu, Mengyu Xiao, Jianying Zhou, Yun He, Xiaolu Zhu, Yuan Kong, Yingjun Chang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3951.

https://doi.org/10.1182/blood-2023-182669

Published: 2023

Journal Articles

Mutations of TP53 Gene in Acute Lymphoblastic Leukemia Do Not Affect the Survival Outcomes after Haploidentical Stem Cell Transplantation

Cuiyan Zhou, Fengmei Zheng, Lanping Xu, Xiaohui Zhang, Yingjun Chang, Xiao-Dong Mo, Yuqian Sun, Xiao-Jun Huang, Yu Wang

Blood (2022) 140 (Supplement 1): 4828–4829.

https://doi.org/10.1182/blood-2022-166060

Published: 2022

Journal Articles

Interferon-α-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia----a Prospective, Single-Arm Study

Xiaohong Liu, Yao Li, Wenjing Yu, Xiaolu Zhu, Jinsong Jia, Lizhong Gong, Xiaosu Zhao, Yingjun Chang, Xiao-Jun Huang, Hao Jiang

Blood (2022) 140 (Supplement 1): 3299–3300.

https://doi.org/10.1182/blood-2022-168422

Published: 2022

Journal Articles

The FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in AML Patients with FLT3-ITD after Allo-HSCT: A Retrospective Propensity-Score Matching Study

Cuiyan Zhou, Fengmei Zheng, Lanping Xu, Xiaohui Zhang, Yingjun Chang, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Xiao-Jun Huang

Blood (2022) 140 (Supplement 1): 7689–7690.

https://doi.org/10.1182/blood-2022-164533

Published: 2022

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Siqi Li, Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Huan Chen, Yu-Hong Chen, Fengrong Wang, Wei Han, Yuqian Sun, Chenhua Yan, Meng Lyu, Feifei Tang, Xiao-Dong Mo, Kai-Yan Liu, Yingjun Chang, Xiao Jun Huang

Blood (2021) 138 (Supplement 1): 517.

https://doi.org/10.1182/blood-2021-150011

Published: 2021

Journal Articles

PRDM1 Is Sufficient for Inducing Human Primary T Cell Hyporesponsiveness and Implicates Low Gvhd Occurrence after Allo-HSCT

Ming Wang, Ming Wang, Bixia Wang, Liping Guo, Yifei Cheng, Zhidong Wang, Yuqian Sun, Yu Wang, Yingjun Chang, Xiaojun Huang

Blood (2021) 138 (Supplement 1): 197.

https://doi.org/10.1182/blood-2021-149394

Published: 2021

Journal Articles

Comparison of Transplant Donor and Third-Party Donor Derived CMV-Specific T Cells for CMV Infection after Allogenic Stem Cell Transplantation

Xuying Pei, Xuefei Liu, Xiang-Yu Zhao, Yingjun Chang, Meng Lv, Xiaodong Mo, Yuqian Sun, Lanping Xu, Yu Wang, Xiaohui Zhang, Xiaojun Huang

Blood (2021) 138 (Supplement 1): 1701.

https://doi.org/10.1182/blood-2021-150915

Published: 2021

Journal Articles

The Application of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in AML-MRC: A Single Center Case Control Study

Hao Jiang, Jing Liu, Xiaohong Liu, Jinsong Jia, Lizhong Gong, Shengye Lu, Xiaojun Huang, Jing Wang, Xiaosu Zhao, Yueyun Lai, Hongxia Shi, Yingjun Chang, Guorui Ruan

Blood (2021) 138 (Supplement 1): 2320.

https://doi.org/10.1182/blood-2021-149493

Published: 2021

Journal Articles

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Jing Wang, MD, Jinsong Jia, Xiaohong Liu, Lizhong Gong, Shengye Lu, Yu Wang, Lanping Xu, Xiaohui Zhang, Chenhua Yan, Yueyun Lai, Xiaosu Zhao, PhD, Yazhen Qin, Guorui Ruan, Yingjun Chang, Hongxia Shi, Kaiyan Liu, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-140977

Published: 2020

Journal Articles

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

Wenbing Duan, Xiaohong Liu, Jinsong JIA, MDPhD, Jing Wang, MD, Lizhong Gong, Qian Jiang, MD, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaosu Zhao, PhD, Yazhen Qin, Hongxia Shi, Yingjun Chang, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-141905

Published: 2020

Journal Articles

Aging-induced IL27Ra signaling impairs hematopoietic stem cells

Hanqing He, Panglian Xu, Xiaofei Zhang, Min Liao, Qiongye Dong, Tingting Cong, Baixue Tang, Xiuxiu Yang, Maoqing Ye, Yingjun Chang, Weihua Liu, Xiaowo Wang, Zhenyu Ju, Jianwei Wang

Blood (2020) 136 (2): 183–198.

https://doi.org/10.1182/blood.2019003910

Published: 2020

Includes: Supplemental data

Journal Articles

Contribution of Myeloid-Drived Suppressor Cells to Leukemia Relapse in Patients with B-ALL Who Underwent Allo-HSCT

Yang Zhou, MD, Yingjun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 2010.

https://doi.org/10.1182/blood-2019-123723

Published: 2019

NARROW

Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

AIM2 Mediates Immune Evasion of Acute Myeloid Leukemia Cells

Outcome for Mothers and Neonates Among Pregnant Women with Von Willebrand Disease: A Prospective Nationwide Multicenter Study

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study

Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Mutations of TP53 Gene in Acute Lymphoblastic Leukemia Do Not Affect the Survival Outcomes after Haploidentical Stem Cell Transplantation

Interferon-α-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia----a Prospective, Single-Arm Study

The FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in AML Patients with FLT3-ITD after Allo-HSCT: A Retrospective Propensity-Score Matching Study

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

PRDM1 Is Sufficient for Inducing Human Primary T Cell Hyporesponsiveness and Implicates Low Gvhd Occurrence after Allo-HSCT

Comparison of Transplant Donor and Third-Party Donor Derived CMV-Specific T Cells for CMV Infection after Allogenic Stem Cell Transplantation

The Application of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in AML-MRC: A Single Center Case Control Study

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

Aging-induced IL27Ra signaling impairs hematopoietic stem cells

Contribution of Myeloid-Drived Suppressor Cells to Leukemia Relapse in Patients with B-ALL Who Underwent Allo-HSCT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only